Efficacy and safety of substituting teneligliptin with hydroxychloroquine in inadequately controlled type 2 diabetes subjects with combination therapy of teneligliptin, metformin and glimepiride with or without other antidiabetic therapy: The TENE-HYQ SHIFT Study

Hydrixychloroquine in Type 2 Diabetes...
NAN Sizes 0 Downloads 0 Views

Recommend Documents

No documents